ClinicalTrials.Veeva
Menu

Find clinical trials for Colon Cancer in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Colonic Cancer
Cancer
Adenocarcinoma
Neoplasm Metastasis
Non-Small-Cell Lung Carcinoma
Carcinoma

Colon Cancer trials near Salt Lake City, UT, USA:

A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

This is an open-label, first-in-human study designed to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor ...

Active, not recruiting
Any Solid Tumor
Colon Cancer
Drug: LOXO-292

Phase 1, Phase 2

Lilly
Lilly

Salt Lake City, Utah, United States and 84 other locations

Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors....

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-6236

Phase 1

Revolution Medicines
Revolution Medicines

Salt Lake City, Utah, United States and 15 other locations

This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor...

Enrolling
Stage III Colon Cancer
Drug: mFOLFOX6 3-6 month
Device: Signatera test

Phase 2, Phase 3

NRG Oncology
NRG Oncology

Salt Lake City, Utah, United States and 957 other locations

This study will test the safety of a drug called PF-08046052/SGN-EGFRd2 in participants with advanced solid tumors. It will also study the s...

Enrolling
Colorectal Neoplasms
Squamous Cell Carcinoma of the Head and Neck
Drug: PF-08046052

Phase 1

Seagen, a wholly owned subsidiary of Pfizer

Salt Lake City, Utah, United States and 22 other locations

of SNS-101, a novel anti VISTA IgG1 monoclonal antibody as monotherapy or in combination with cemiplimab in patients with advanced solid tumors...

Enrolling
Breast Cancer
Uterine Cancer
Drug: Cemiplimab
Drug: SNS-101 (anti-VISTA)

Phase 1, Phase 2

Sensei Biotherapeutics

West Valley City, Utah, United States of America and 10 other locations

Study CA239-0006 is an open-label, randomized Phase 3 clinical trial comparing the efficacy of MRTX849 administered in combination with cetuximab ver...

Active, not recruiting
Metastatic Colorectal Cancer
Advanced Colorectal Cancer
Drug: MRTX849
Biological: Cetuximab

Phase 3

Mirati Therapeutics
Mirati Therapeutics

Salt Lake City, Utah, United States and 427 other locations

versus a fluoropyrimidine/bevacizumab alone as assessed by molecular response which is based on changes in circulating tumor (ct)DNA. The...

Active, not recruiting
Colorectal Neoplasms
Drug: Ipilimumab
Drug: Atezolizumab

Phase 2, Phase 3

Seattle Project Corporation

Salt Lake City, Utah, United States and 42 other locations

and efficacy of 9-ING-41, a potent GSK-3β inhibitor, as a single agent and in combination with cytotoxic agents, in patients with refractory cancers...

Active, not recruiting
Neoplasm of Lung
Neoplasms Pancreatic
Drug: Gemcitabine - 21 day cycle
Drug: 9-ING-41

Phase 2

Actuate Therapeutics

Salt Lake City, Utah, United States and 65 other locations

treatment) or* are metastatic (has spread to other parts of the body).This includes (but limited to) the following cancer types:* Non-Small...

Active, not recruiting
Neoplasms
Non-small-cell Lung Cancer
Biological: sasanlimab
Other: SOC (anti-PD-1 + platinum -based chemo)

Phase 1

Pfizer
Pfizer

West Valley City, Utah, United States of America and 6 other locations

without biological agent and monalizumab (IPH2201) with biological agent administered to participants with recurrent or metastatic colorectal cancer...

Active, not recruiting
Advanced Solid Tumors
Drug: Durvalumab
Drug: Bevacizumab

Phase 1, Phase 2

MedImmune
MedImmune

Salt Lake City, Utah, United States and 48 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems